NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Posted: May 28, 2026 12:00:00 AM EDT
Closes: 04/05/2029
Description
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).
Synopsis
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).
Eligibility
Eligible Applicants:
Only United States small business concerns (SBCs) that have previously received an NIH SBIR or STTR Phase II award are eligible to submit applications for this opportunity. Only one NIH Phase IIB Strategic Breakthrough award is allowed per project. This NOFO supports Renewal/Resubmission "Type 2" Applications from recipients with NIH Phase II SBIR/STTR awards that are submitted within the first six due dates following the expiration of their budget period. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Funding Activity Categories
CFDA Numbers
- 93.233 - National Center on Sleep Disorders Research
- 93.242 - Mental Health Research Grants
- 93.273 - Alcohol Research Programs
- 93.307 - Minority Health and Health Disparities Research
- 93.313 - NIH Office of Research on Women's Health
- 93.350 - National Center for Advancing Translational Sciences
- 93.351 - Research Infrastructure Programs
- 93.393 - Cancer Cause and Prevention Research
- 93.394 - Cancer Detection and Diagnosis Research
- 93.395 - Cancer Treatment Research
- 93.837 - Cardiovascular Diseases Research
- 93.838 - Lung Diseases Research
- 93.839 - Blood Diseases and Resources Research
- 93.840 - Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
- 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research
- 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders
- 93.855 - Allergy and Infectious Diseases Research
- 93.859 - Biomedical Research and Research Training
- 93.865 - Child Health and Human Development Extramural Research
- 93.866 - Aging Research
- 93.867 - Vision Research
Contact Information
Agency: National Institutes of Health
Contact: National Institutes of Health
Email: SEEDinfo@nih.gov
Phone: 301-402-2541
NIH SEED (Small business Education and Entrepreneurial Development)
SEEDinfo@nih.gov
SEEDinfo@nih.gov
Additional Information
Document Type: synopsis
Opportunity Category: Discretionary
Version: 2
Last Updated: Jun 01, 2026 12:56:46 PM EDT
Related Opportunities
Ask Questions
- Can you provide a brief, easy-to-understand summary of this grant opportunity?
- What types of projects or activities would be a good fit for this grant?
- What are the key eligibility requirements and who is most likely to qualify for this grant?
- What are the most important deadlines and timeline considerations for this grant?
- What are the typical costs and budget considerations for projects funded by this grant?
- What are common challenges or pitfalls to avoid when applying for this grant?
- How competitive is this grant and what can improve my chances of success?
- Ask any question...